Digital Biomarkers for Alzheimer's Disease Drug Development

Sign up to hear our Clinical Scientist, Jen Blankenship, PhD., present at Digital Biomarkers and Clinical Measures in Neurology conference July 12th in Boston, MA. She'll discuss key considerations and opportunities for how digital clinical measures can accelerate Alzheimer's Disease drug development. You'll get new insights about:

• Addressing an unmet need in Alzheimer’s disease clinical trials using digital clinical measures
• Translating meaningful aspects of health in Alzheimer’s disease to measurable digital outcomes
• Promising candidate digital clinical measures and key steps to facilitate their acceptance in Alzheimer’s disease drug development

We'll email you a reminder about the presentation if you are going to attend live and a link to watch the presentation on-demand after the conference.

Sign up today!